Abstract
The global health threat posed by the rise of antibiotic-resistant bacteria has resulted in renewed interest in the therapeutic potential of phage therapy for public healthcare. A future phage industry requires underpinning research to support scalable cost-effective manufacturing processes for the production of phage products as well as development of stable pharmaceutical formulations including consideration of aspects related to controlled release and targeted delivery to meet the needs of infectious disease management. Successful phage therapy clinical trials leading to regulatory approval will accelerate the need for product differentiation and innovation. Here we outline innovative approaches relevant to the manufacturing of phage therapeutics, including pharmaceutical formulations suitable for applications related to diverse fields including veterinary and clinical medicine, rapid diagnostics, food safety and biocontrol. We also evaluate the potential benefits of the introduction of synthetic biology approaches in the production of phage therapeutics.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abdelwahed W, Degobert G, Stainmesse S, Fessi H (2006) Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv Drug Deliv Rev 58:1688–1713. https://doi.org/10.1016/j.addr.2006.09.017
Ackermann H-W, Tremblay D, Moineau S (2004) Long-term bacteriophage preservation. WFCC Newsl 38:35–40
Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE (2009) Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev 61:428–437
Ahn H, Park JH (2016) Liposomal delivery systems for intestinal lymphatic drug transport. Biomater Res 20:36. https://doi.org/10.1186/s40824-016-0083-1
Albino LAA, Rostagno MH, Hungaro HM, Mendonca RCS (2014) Isolation, characterization and application of bacteriophages for Salmonella spp. biocontrol in pigs. Foodborne Pathog Dis 11:602–609
American Society for Microbiology (2016) Applications of clinical microbial next-generation sequencing: report on an American Academy of Microbiology Colloquium held in Washington, DC, in April 2015. Washington (DC). https://doi.org/10.1128/AAMCol.Apr.2015
Amgarten D, Braga LPP, da Silva AM, Setubal JC (2018) MARVEL, a tool for prediction of bacteriophage sequences in metagenomic bins. Front Genet 9:304. https://doi.org/10.3389/fgene.2018.00304
Amidon S, Brown JE, Dave VS (2015) Colon-targeted oral drug delivery systems: design trends and approaches. AAPS PharmSciTech 16:731–741. https://doi.org/10.1208/s12249-015-0350-9
Anany H, Chen W, Pelton R, Griffiths MW (2011) Biocontrol of Listeria monocytogenes and Escherichia coli O157:H7 in meat by using phages immobilized on modified cellulose membranes. Appl Environ Microbiol 77:6379–6387. https://doi.org/10.1128/AEM.05493-11
Anany H, Brovko L, El Dougdoug NK, Sohar J, Fenn H, Alasiri N, Jabrane T, Mangin P, Monsur Ali M, Kannan B, Filipe CDM, Griffiths MW (2018) Print to detect: a rapid and ultrasensitive phage-based dipstick assay for foodborne pathogens. Anal Bioanal Chem 410:1217–1230. https://doi.org/10.1007/s00216-017-0597-y
Ando H, Lemire S, Pires DP, Lu TK (2015) Engineering modular viral scaffolds for targeted bacterial population editing. Cell Syst 1:187–196
Applegate PM, Perry LL, Morgan MT, Kothapalli A (2009) Methods for regeneration of reporter phages and immobilization of active phages on a polymer surface. US Patent 8,114,622 B2
Balasubramanian S, Sorokulova IB, Vodyanoy VJ, Simonian AL (2007) Lytic phage as a specific and selective probe for detection of Staphylococcus aureus—a surface plasmon resonance spectroscopic study. Biosens Bioelectron 22:948–955. https://doi.org/10.1016/j.bios.2006.04.003
Balcao VM, Glasser CA, Chaud MV, del Fiol FS, Tubino M, Vila MMDC (2014) Biomimetic aqueous-core lipid nanoballoons integrating a multiple emulsion formulation: a suitable housing system for viable lytic bacteriophages. Colloids Surf B Biointerfaces 123:478–485. https://doi.org/10.1016/j.colsurfb.2014.09.045
Baldwin D, Summer N (2011) Process for continuous production of bacteriophage. US Patent 8,252,519 B2
Bangham AD, Horne RW (1964) Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope. J Mol Biol 8:660–668
Barbu EM, Cady KC, Hubby B (2016) Phage therapy in the era of synthetic biology. Cold Spring Harb Perspect Biol 8(10):a023879. https://doi.org/10.1101/cshperspect.a023879
Basnet P, Hussain H, Tho I, Skalko-Basnet N (2012) Liposomal delivery system enhances anti-inflammatory properties of curcumin. J Pharm Sci 101:598–609. https://doi.org/10.1002/jps.22785
Bean JE, Alves DR, Laabei M, Esteban PP, Thet NT, Enright MC, Jenkins TA (2014) Triggered release of bacteriophage K from agarose/hyaluronan hydrogel matrixes by Staphylococcus aureus virulence factors. Chem Mater 26:7201–7208
Beloqui A, Coco R, Alhouayek M, Solinis MA, Rodriguez-Gascon A, Muccioli GG, Preat V (2013) Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis. Int J Pharm 454:775–783
Bennett AR, Davids FG, Vlahodimou S, Banks JG, Betts RP (1997) The use of bacteriophage-based systems for the separation and concentration of Salmonella. J Appl Microbiol 83:259–265
Boggione DMG, Batalha LS, Gontijo MTP, Lopez MES, Teixeira AVNC, Santos IJB, Mendonca RCS (2017) Evaluation of microencapsulation of the UFV-AREG1 bacteriophage in alginate-Ca microcapsules using microfluidic devices. Colloids Surf B Biointerfaces 158:182–189. https://doi.org/10.1016/j.colsurfb.2017.06.045
Boratynski J, Gorski A, Weber-Dabrowska B, Szermer-Olearnik B (2008) Method of obtaining bacteriophage preparation. US 2010/0227376 A1
Boss P, Lieberman S (2006) Technique for orienting and binding phage for bacteria detection. US Patent 7,632,637 B1
Bourdin G, Schmitt B, Guy LM, Germond JE, Zuber S, Michot L, Reuteler G, Brüssow H (2014) Amplification and purification of T4-like Escherichia coli phages for phage therapy: from laboratory to pilot scale. Appl Environ Microbiol 80:1469–1476. https://doi.org/10.1128/AEM.03357-13
Brovko LY, Anany H, Griffiths MW (2012) Bacteriophages for detection and control of bacterial pathogens in food and food-processing environment. Adv Food Nutr Res 67:241–288. https://doi.org/10.1016/B978-0-12-394598-3.00006-X
Brown R, Lengeling A, Wang B (2017) Phage engineering: how advances in molecular biology and synthetic biology are being utilized to enhance the therapeutic potential of bacteriophages. Quant Biol 5:42–54. https://doi.org/10.1007/s40484-017-0094-5
Bujanover S (2003) Production of bacteriophage compositions for use in phage therapy. US 2007/0010001 A1
Bulbake U, Doppalapudi S, Kommineni N, Khan W (2017) Liposomal formulations in clinical use: an updated review. Pharmaceutics 9:E12. https://doi.org/10.3390/pharmaceutics9020012
Cademartiri R, Anany H, Gross I, Bhayani R, Griffiths M, Brook MA (2010) Immobilization of bacteriophages on modified silica particles. Biomaterials 31:1904–1910. https://doi.org/10.1016/j.biomaterials.2009.11.029
Calvagno MG, Celia C, Paolino D, Cosco D, Iannone M, Castelli F, Doldo P, Frest M (2007) Effects of lipid composition and preparation conditions on physical-chemical properties, technological parameters and in vitro biological activity of gemcitabine-loaded liposomes. Curr Drug Deliv 4:89–101
Campos-Martorell M, Cano-Sarabia M, Simats A, Hernández-Guillamon M, Rosell A, Maspoch D, Montaner J (2016) Charge effect of a liposomal delivery system encapsulating to treat experimental ischemic stroke in rats. Int J Nanomedicine 11:3035–3048. https://doi.org/10.2147/IJN.S107292
Carrigy NB, Chang RY, Leung SSY, Harrison M, Petrova Z, Pope WH, Hatfull GF, Britton WJ, Chan HK, Sauvageau D, Finlay WH, Vehring R (2017) Anti-tuberculosis bacteriophage D29 delivery with a vibrating mesh nebulizer, jet nebulizer, and soft mist inhaler. Pharm Res 34:2084–2096. https://doi.org/10.1007/s11095-017-2213-4
Carvalho Leite DM, Brochet X, Resch G, Que YA, Neves A, Peña-Reyes C (2017) Computational prediction of host-pathogen interactions through Omics data analysis and machine learning. In: Rojas I, Ortuño F (eds) Bioinformatics and biomedical engineering. IWBBIO 2017, Lecture notes in computer science, vol 10209. Springer, Cham, pp 360–371
Cavaletti G, Cassetti A, Canta A, Galbiati S, Gilardini A, Oggioni N, Rodriguez-Menendez V, Fasano A, Liuzzi GM, Fattler U, Ries S, Nieland J, Riccio P, Haas H (2009) Cationic liposomes target sites of acute neuroinflammation in experimental autoimmune encephalomyelitis. Mol Pharm 6:1363–1370. https://doi.org/10.1021/mp8001478
Chadha P, Katare OP, Chhibber S (2017) Liposome loaded phage cocktail: enhanced therapeutic potential in resolving Klebsiella pneumoniae mediated burn wound infections. Burns 43:1532–1543
Chadwick J, Mattey M (2012) Delivery of viral agents. WO 2012/175749A1
Chang RY, Wong J, Mathai A, Morales S, Kutter E, Britton W, Li J, Chan HK (2017) Production of highly stable spray dried phage formulations for treatment of Pseudomonas aeruginosa lung infection. Eur J Pharm Biopharm 121:1–13. https://doi.org/10.1016/j.ejpb.2017.09.002
Chen H, Pan H, Li P, Wang H, Wang X, Pan W, Yuan Y (2016) The potential use of novel chitosan-coated deformable liposomes in an ocular drug delivery system. Colloids Surf B Biointerfaces 43:455–462. https://doi.org/10.1016/j.colsurfb.2016.03.061
Chew NYK, Chan HK (2002) The role of particle properties in pharmaceutical powder inhalation formulations. J Aerosol Med 15:325–330
Chhibber S, Kaur J, Kaur S (2018) Liposome entrapment of bacteriophages improves wound healing in a diabetic mouse MRSA infection. Front Microbiol 9:561. https://doi.org/10.3389/fmicb.2018.00561
Choi IY, Park JH, Gwak KM, Kim KP, Oh JH, Park MK (2018) Studies on lytic, tailed Bacillus cereus-specific phage for use in a ferro magnetoelastic biosensor as a novel recognition element. J Microbiol Biotechnol 28:87–94. https://doi.org/10.4014/jmb.1710.10033
Choonara BF, Choonara YE, Kumar P, Bijukumar D, du Toit LC, Pillay V (2014) A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules. Biotechnol Adv 32:1269–1282. https://doi.org/10.1016/j.biotechadv.2014.07.006
Cinquerrui S, Mancuso F, Vladisavljević GT, Bakker SE, Malik DJ (2018) Nanoencapsulation of bacteriophages in liposomes prepared using microfluidic hydrodynamic flow focusing. Front Microbiol 9:2172. https://doi.org/10.3389/fmicb.2018.02172
Colom J, Cano-Sarabia M, Otero J, Cortés P, Maspoch D, Llagostera M (2015) Liposome encapsulated bacteriophages for enhanced oral phage therapy against Salmonella spp. Appl Environ Microbiol 81:4841–4849. https://doi.org/10.1128/AEM.00812-15
Colom J, Cano-Sarabia M, Otero J, Aríñez-Soriano J, Cortés P, Maspoch D, Llagostera M (2017) Microencapsulation with alginate/CaCO3: a strategy for improved phage therapy. Sci Rep 7:41441. https://doi.org/10.1038/srep41441
Comeau AM, Tétart F, Trojet SN, Prère MF, Krisch HM (2007) Phage-antibiotic synergy (PAS): beta-lactam and quinolone antibiotics stimulate virulent phage growth. PLoS One 2:e799. https://doi.org/10.1371/journal.pone.0000799
Cooper IR, Illsley M, Korobeinyk AV, Whitby RLD (2015) Bacteriophage-nanocomposites: an easy and reproducible method for the construction, handling, storage and transport of conjugates for deployment of bacteriophages active against Pseudomonas aeruginosa. J Microbiol Methods 111:111–118. https://doi.org/10.1016/j.mimet.2015.02.005
Cu Y, Saltzman WM (2009) Stealth particles give mucus the slip. Nat Mater 8:11–13. https://doi.org/10.1016/j.immuni.2010.12.017
Curtin JJ, Donlan RM (2006) Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis. Antimicrob Agents Chemother 50:1268–1275
Dai M, Senecal A, Nugen SR (2014) Electrospun water-soluble polymer nanofibers for the dehydration and storage of sensitive reagents. Nanotechnology 25:225101. https://doi.org/10.1088/0957-4484/25/22/225101
Davies JD, Kelly MJ (1969) The preservation of bacteriophage H1 of Corynebacterium ulcerans U103 by freeze-drying. J Hyg 67:573–583. https://doi.org/10.1017/S0022172400042030
Davis SS, Hardy JG, Fara JW (1986) Transit of pharmaceutical dosage forms through the small intestine. Gut 27:886–892. https://doi.org/10.1136/gut.27.8.886
Dini C, de Urraza PJ (2013) Effect of buffer systems and disaccharides concentration on Podoviridae coliphage stability during freeze drying and storage. Cryobiology 66:339–342. https://doi.org/10.1016/j.cryobiol.2013.03.007
Dini C, Islan GA, de Urraza PJ, Castro GR (2012) Novel biopolymer matrices for microencapsulation of phages: enhanced protection against acidity and protease activity. Macromol Biosci 12:1200–1208. https://doi.org/10.1002/mabi.201200109
Dixon DV, Hosseinidoust Z, Tufenkji N (2014) Effects of environmental and clinical interferents on the host capture efficiency of immobilized bacteriophages. Langmuir 30:3184–3190. https://doi.org/10.1021/la500059u
Donlan RM, Lehman SM, Garcia AJ (2016) Controlled covalent attachment of bioactive bacteriophage for regulating biofilm development. US Patent 9,457,132 B2
Elliott EJ (2016) Method and apparatus of improved bacteriophage yield. WO 2017/079806 A1
Engel HWB, Smith D, Berwald LG (1974) The preservation of mycobacteriophages by means of freeze drying. Am Rev Respir Dis 109:561–566
Ernsting MJ, Murakami M, Roy A, Li SD (2013) Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles. J Control Release 172:782–794. https://doi.org/10.1016/j.jconrel.2013.09.013
Esteban PP, Alves DR, Enright MC, Bean JE, Gaudion A, Jenkins ATA, Young AE, Arnot TC (2014) Enhancement of the antimicrobial properties of bacteriophage-K via stabilization using oil-in-water nano-emulsions. Biotechnol Prog 30:932–944. https://doi.org/10.1002/btpr.1898
Ghanbari HA, Averback P (1997) Compositions containing bacteriophages and methods of using bacteriophages to treat infections. US Patent 6,121,036
Gibson DG, Young L, Chuang RY, Venter JC, Hutchison CA 3rd, Smith HO (2009) Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat Methods 6:343–345
Golshahi L, Lynch KH, Dennis JJ, Finlay WH (2010) In vitro lung delivery of bacteriophages KS4-M and φKZ using dry powder inhalers for treatment of Burkholderia cepacia complex and Pseudomonas aeruginosa infections in cystic fibrosis. J Appl Microbiol 110:106–117. https://doi.org/10.1111/j.1365-2672.2010.04863.x
Griffiths M, Anany H, Brovko L (2015) Active phage-based inks, methods of printing on materials and phage-based bioactive. US 2016/0024478 A1
Handa H, Gurczynski S, Jackson MP, Auner G, Walker J, Mao G (2008) Recognition of Salmonella typhimurium by immobilized phage P22 monolayers. Surf Sci 602:1392–1400. https://doi.org/10.1016/j.susc.2008.01.036
Hathaway H, Alves DR, Bean J, Esteban PP, Ouadi K, Sutton JM, Jenkins AT (2015) Poly (N-isopropylacrylamide-co-allylamine) (PNIPAM-co-ALA) nanospheres for the thermally triggered release of Bacteriophage K. Eur J Pharm Biopharm 96:437–441. https://doi.org/10.1016/j.ejpb.2015.09.013
Hoe S, Ivey JW, Boraey MA, Shamsaddini-Shahrbabak A, Javaheri E, Matinkhoo S, Finlay WH, Vehring R (2014) Use of a fundamental approach to spray-drying formulation design to facilitate the development of multi-component dry powder aerosols for respiratory drug delivery. Pharm Res 31:449–465. https://doi.org/10.1007/s11095-013-1174-5
Holdich RG, Dragosavac MM, Vladisavljević GT, Kosvintsev SR (2010) Membrane emulsification with oscillating and stationary membranes. Ind Eng Chem Res 49:3810–3817. https://doi.org/10.1021/ie900531n
Hosseinidoust Z, Olsson AL, Tufenkji N (2014) Going viral: designing bioactive surfaces with bacteriophage. Colloids Surf B Biointerfaces 124:2–16. https://doi.org/10.1016/j.colsurfb.2014.05.036
Hua S, Marks E, Schneider JJ, Keely S (2015) Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue. Nanomed Nanotechnol Biol Med 11:1117–1132. https://doi.org/10.1016/j.nano.2015.02.018
Huang M, Fong CW, Khor E, Lim LY (2005) Transfection efficiency of chitosan vectors: effect of polymer molecular weight and degree of deacetylation. J Control Release 106:391–406
Huang ZH, Li X, Zhang T, Song Y, She ZH, Li J, Deng Y (2014) Progress involving new techniques for liposome preparation. Asian J Pharm Sci 9:176–182
Husimi Y, Nishigaki K, Kinoshita Y, Tanaka T (1982) Cellstat-A continuous culture system of a bacteriophage for the study of the mutation rate and the selection process at the DNA level. Rev Sci Instrum 53:517–522. https://doi.org/10.1063/1.1137002
Hwang IY, Lee HL, Huang JG, Lim YY, Yew WS, Lee YS, Chang MW (2018) Engineering microbes for targeted strikes against human pathogens. Cell Mol Life Sci 75:2719–2733
Ibekwe VC, Fadda HM, McConnell EL, Khela MK, Evans DF, Basit AW (2008) Interplay between intestinal pH, transit time and feed status on the in vivo performance of pH responsive ileo-colonic release systems. Pharm Res 25:1828–1835. https://doi.org/10.1007/s11095-008-9580-9
Immordino ML, Dosio F, Cattel L (2006) Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomedicine 1:297–315
Jabrane T, Jeaidi J, Dubé M, Mangin PJ (2008) Gravure printing of enzymes and phages. Adv Print Media Technol 35:279–288
Jain D, Panda AK, Majumdar DK (2005) Eudragit S100 entrapped insulin microspheres for oral delivery. AAPS PharmSciTech 6:E100–E107. https://doi.org/10.1208/pt060116
Jamalludeen N, Johnson RP, Shewen PE, Gyles CL (2009) Evaluation of bacteriophages for prevention and treatment of diarrhea due to experimental enterotoxigenic Escherichia coli O149 infection of pigs. Vet Microbiol 136:135–141. https://doi.org/10.1016/j.vetmic.2008.10.021
Jault P, Leclerc T, Jennes S, Pirnay JP, Que YA, Resch G, Rousseau AF, Ravat F, Carsin H, Le Floch R, Schaal JV, Soler C, Fevre C, Arnaud I, Bretaudeau L, Gabard J (2018) Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial. Lancet Infect Dis 19(1):35–45. https://doi.org/10.1016/S1473-3099(18)30482-1
Jikia D, Chkhaidze N, Imedashvili E, Mgaloblishvili I, Tsitlanadze G, Katsarava R, Glenn Morris J Jr, Sulakvelidze A (2005) The use of a novel biodegradable preparation capable of the sustained release of bacteriophages and ciprofloxacin, in the complex treatment of multidrug-resistant Staphylococcus aureus-infected local radiation injuries caused by exposure to Sr90. Clin Exp Dermatol 30:23–26
Jończyk E, Kłak M, Międzybrodzki R, Górski A (2011) The influence of external factors on bacteriophages—review. Folia Microbiol (Praha) 56:191–200. https://doi.org/10.1007/s12223-011-0039-8
Jubeh TT, Baenholz Y, Rubinstein A (2004) Differential adhesion of normal and inflamed rat colonic mucosa by charged liposomes. Pharm Res 21:447–453. https://doi.org/10.1023/B:PHAM.0000019298.29561.cd
Katsarava R, Alavidze Z (2001) Polymer blends as biodegradable matrices for preparing biocomposites. US Patent 6,703,040 B2
Katsarava R, Tugushi D, Gomurashvili ZD (2006) Poly(ester urea) polymers and methods of use. US 2007/0128250 A1
Katsarava R, Tugushi D, Beridze V, Tawil N (2016) Composition comprising a polymer and bioactive agent and method of preparing thereof. US 2016/0375139 A1
Keen EC (2015) A century of phage research: bacteriophages and the shaping of modern biology. BioEssays 37:6–9. https://doi.org/10.1002/bies.201400152
Kilcher S, Studer P, Muessner C, Klumpp J, Loessner MJ (2018) Cross-genus rebooting of custom-made, synthetic bacteriophage genomes in L-form bacteria. Proc Natl Acad Sci U S A 115:567–572
Kim S, Jo A, Ahn J (2015) Application of chitosan-alginate microspheres for the sustained release of bacteriophage in simulated gastrointestinal conditions. Int J Food Sci Technol 50:913–918. https://doi.org/10.1111/ijfs.12736
Klingler C, Müller BW, Steckel H (2009) Insulin-micro- and nanoparticles for pulmonary delivery. Int J Pharm 377:173–179. https://doi.org/10.1016/j.ijpharm.2009.05.008
Knezevic P, Curcin S, Aleksic V, Petrusic M, Vlaski L (2013) Phage-antibiotic synergism: a possible approach to combating Pseudomonas aeruginosa. Res Microbiol 164:55–60. https://doi.org/10.1016/j.resmic.2012.08.008
Kong T, Wu J, To M, Wai Kwok Yeung K, Cheung Shum H, Wang L (2012) Droplet based microfluidic fabrication of designer microparticles for encapsulation applications. Biomicrofluidics 6(3):34104. https://doi.org/10.1063/1.4738586
Koping-Hoggard M, Tubulekas I, Guan H, Edwards K, Nilsson M, Varum KM, Artursson P (2001) Chitosan as a nonviral gene delivery system. Structure–property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo. Gene Ther 8:1108–1121
Korehei R, Kadla J (2013) Incorporation of T4 bacteriophage in electrospun fibres. J Appl Microbiol 114:1425–1434. https://doi.org/10.1111/jam.12158
Korehei R, Kadla JF (2014) Encapsulation of T4 bacteriophage in electrospun poly(ethylene oxide)/cellulose diacetate fibers. Carbohydr Polym 100:150–157. https://doi.org/10.1016/j.carbpol.2013.03.079
Kosvintsev SR, Gasparini G, Holdich RG, Cumming IW, Stillwell MT (2005) Liquid-liquid membrane dispersion in a stirred cell with and without controlled shear. Ind Eng Chem Res 44:9323–9330
Krisch HM, Prere MF, Tetart F (2007) Process of production bacteriophage compositions and methods in phage therapy field. US Patent 8,178,087 B2
Krysiak-Baltyn K, Martin GJO, Gras SL (2018) Computational modelling of large scale phage production using a two-stage batch process. Pharmaceuticals 11(2):31. https://doi.org/10.3390/ph11020031
Kuhl SJ, Mazure H (2011) d’Hérelle. Preparation of therapeutic bacteriophages, Appendix 1 from: Le Phénomène de la Guérison dans les maladies infectieuses: Masson et Cie, 1938, Paris—OCLC 5784382. Bacteriophage 1(2):55–65. https://doi.org/10.4161/bact.1.2.1568
Kuhn JC, Zussman E (2007) Encapsulation of bacteria and viruses in electrospun fibers. US2009/0061496A1
Kukizaki M (2009) Shirasu porous glass (SPG) membrane emulsification in the absence of shear flow at the membrane surface: influence of surfactant type and concentration, viscosities of dispersed and continuous phases, and transmembrane pressure. J Membr Sci 327:234–243. https://doi.org/10.1016/j.memsci.2008.11.026
Lee SW, Belcher AM (2004) Virus-based fabrication of micro- and nanofibers using electrospinning. Nano Lett 4:387–390. https://doi.org/10.1021/nl034911t
Lehnherr H, Bartsch R (2007) Process and system for the industrial scale purification of bacteriophages intended for bacteriophage therapy. European Patent 2,195,418 B1
Lemire S, Yehl KM, Lu TK (2018) Phage-based applications in synthetic biology. Annu Rev Virol 5:453–476
Leung SSY, Parumasivam T, Gao FG, Carrigy NB, Vehring R, Finlay WH, Morales S, Britton WJ, Kutter E, Chan HK (2016) Production of inhalation phage powders using spray freeze drying and spray drying techniques for treatment of respiratory infections. Pharm Res 33:1486–1496. https://doi.org/10.1007/s11095-016-1892-6
Leung SSY, Parumasivam T, Gao FG, Carrigy NB, Vehring R, Finlay WH, Morales S, Britton WJ, Kutter E, Chan HK (2017) Effects of storage conditions on the stability of spray dried, inhalable bacteriophage powders. Int J Pharm 521(1–2):141–149. https://doi.org/10.1016/j.ijpharm.2017.01.060
Leung SSY, Morales S, Britton W, Kutter E, Chan HK (2018) Microfluidic-assisted bacteriophage encapsulation into liposomes. Int J Pharm 545:176–182. https://doi.org/10.1016/j.ijpharm.2018.04.063
Li SD, Huang L (2008) Pharmacokinetics and biodistribution of nanoparticles. Mol Pharm 5:496–504. https://doi.org/10.1021/mp800049w
Lin DM, Koskella B, Lin HC (2017) Phage therapy: an alternative to antibiotics in the age of multi-drug resistance. World J Gastrointest Pharmacol Ther 8:162–173. https://doi.org/10.4292/wjgpt.v8.i3.162
Lindemann BF, Klug C, Schwienhorst A (2002) Evolution of bacteriophage in continuous culture: a model system to test antiviral gene therapies for the emergence of phage escape mutants. J Virol 76:5784–5792. https://doi.org/10.1128/JVI.76.11.5784
Łobocka M, Hejnowicz MS, Gągała U, Weber-Dąbrowska B, Grzegorz Węgrzyn G, Dadlez M (2014) The first step to bacteriophage therapy - how to choose the correct phage. In: Borysowski J, Międzybrodzki R, Gorski A (eds) Phage therapy: current research and applications. Caister Academic, Norfolk, pp 23–68
Lone A, Anany H, Hakeem M, Aguis L, Avdjian AC, Bouget M (2016) Development of prototypes of bioactive packaging materials based on immobilized bacteriophages for control of growth of bacterial pathogens in foods. Int J Food Microbiol 217:49–58. https://doi.org/10.1016/j.ijfoodmicro.2015.10.011
Ma Y, Pacan JC, Wang Q, Xu Y, Huang X, Korenevsky A, Sabour PM (2008) Microencapsulation of bacteriophage Felix O1 into chitosan-alginate microspheres for oral delivery. Appl Environ Microbiol 74:4799–4805. https://doi.org/10.1128/AEM.00246-08
Ma Y, Pacan JC, Wang Q, Sabour PM, Huang X, Xu Y (2012) Enhanced alginate microspheres as means of oral delivery of bacteriophage for reducing Staphylococcus aureus intestinal carriage. Food Hydrocoll 26:434–440. https://doi.org/10.1016/j.foodhyd.2010.11.017
Majlessi L, Brosch R (2015) Mycobacterium tuberculosis meets the cytosol: the role of cGAS in anti-mycobacterial immunity. Cell Host Microbe 17:733–735. https://doi.org/10.1016/j.chom.2015.05.017
Malenovská H (2014) The influence of stabilizers and rates of freezing on preserving of structurally different animal viruses during lyophilization and subsequent storage. J Appl Microbiol 117:1810–1809. https://doi.org/10.1111/jam.12654
Malik DJ (2019) Targeted delivery of bacteriophages to the gastrointestinal tract and their controlled release: unleashing the therapeutic potential of phage therapy. In: Faintuch J, Faintuch S (eds) Microbiome and metabolome in diagnosis, therapy, and other strategic applications, 1st edn. Academic Press, New York
Malik DJ, Sokolov IJ, Vinner GK, Mancuso F, Cinquerrui S, Vladisavljevic GT, Clokie MRJ, Garton NJ, Stapley AGF, Kirpichnikova A (2017) Formulation, stabilisation and encapsulation of bacteriophage for phage therapy. Adv Colloid Interf Sci 249:100–133. https://doi.org/10.1016/j.cis.2017.05.014
Mancuso F, Shi J, Malik DJ (2018) High throughput manufacturing of bacteriophages using continuous stirred tank bioreactors connected in series to ensure optimum host bacteria physiology for phage production. Viruses 10(10):537. https://doi.org/10.3390/v10100537
Markoishvili K, Tsitlanadze G, Katsarava R, Morris JG Jr, Sulakvelidze A (2002) A novel sustained-release matrix based on biodegradable poly(ester amide)s and impregnated with bacteriophages and an antibiotic shows promise in management of infected venous stasis ulcers and other poorly healing wounds. Int J Dermatol 41:453–458
Matinkhoo S, Lynch KH, Dennis JJ, Finlay WH, Vehring R (2011) Spray-dried respirable powders containing bacteriophages for the treatment of pulmonary infections. J Pharm Sci 100:5197–5205
Mattey M, Bell EL (2017) Treatment of topical and systemic bacterial infections. US 2017/0020937 A1
Mattey M, Chadwick J (2016) Treatment of intracellular bacterial infection. US Patent 9,278,141 B2
Mattey M, Wilkinson RI (2013) Particle binding. US 2013/0040355 A1
McConnell EL, Fadda HM, Basit AW (2008) Gut instincts: explorations in intestinal physiology and drug delivery. Int J Pharm 364:213–226. https://doi.org/10.1016/j.ijpharm.2008.05.012
Merabishvili M (2014) Production of bacteriophages using bacterial suspension cultures for phage-therapy. In: Meyer HP, Schmidalter DR (eds) Industrial scale suspension culture of living cells. Wiley, Weinheim, pp 537–543
Merabishvili M, De Vos D, Verbeken G, Kropinski AM, Vandenheuvel D, Lavigne R, Wattiau P, Mast J, Ragimbeau C, Mossong J, Scheres J, Chanishvili N, Vaneechoutte M, Pirnay JP (2012) Selection and characterization of a candidate therapeutic bacteriophage that lyses the Escherichia coli O104:H4 strain from the 2011 outbreak in Germany. PLoS One 7:e52709
Merabishvili M, Vervaet C, Pirnay JP, de Vos D, Verbeken G, Mast J, Chanishvili N, Vaneechoutte M (2013) Stability of Staphylococcus aureus phage ISP after freeze-drying (lyophilization). PLoS One 8(7):e68797. https://doi.org/10.1371/journal.pone.0068797
Minikh O, Tolba M, Brovko LY, Griffiths MW (2010) Bacteriophage-based biosorbents coupled with bioluminescent ATP assay for rapid concentration and detection of Escherichia coli. J Microbiol Methods 82:177–183. https://doi.org/10.1016/j.mimet.2010.05.01
Ministry of Health of the USSR (1987) Reglament proizvodstva antitifoznogo bakteriofaga v tabletkakh s kislotostoikim pokrititem 88. (Guidelines for production of anti-typhoidal phage tablets with acid resistant covering 88). Moscow
Mohamed A, Xing MM (2012) Nanomaterials and nanotechnology for skin tissue engineering. Int J Burns Trauma 2:29–41
Morris JG, Sulakvelidze A, Alavidze Z, Pasternack G, Brown T (2003) Reduction in bacterial colonization by administrating bacteriophage compositions. US Patent 7,459,272 B2
Mosa M, Bostik J, Pantucek R, Doskar J (2013) Medicinal preparations in the form of antistaphylococcal phage lysate, process of its preparation and use. WO 2014/048407 A2
Muller R (2009) Method for producing a mixture of bacteriophages and the use thereof in the therapy of antibiotic-resistant staphylococci. US 2011/0014157 A1
Nabergoj D, Kuzmic N, Drakslar B, Podgornik A (2018) Effect of dilution rate on productivity of continuous bacteriophage production in cellstat. Appl Microbiol Biotechnol 102:3649–3661. https://doi.org/10.1007/s00253-018-8893-9
Nieth A, Verseux C, Barnert S, Süss R, Römer W (2015) A first step toward liposome mediated intracellular bacteriophage therapy. Expert Opin Drug Deliv 12:1411–1424. https://doi.org/10.1517/17425247.2015.1043125
Nogueira F, Karumidze N, Kusradze I, Goderdzishvili M, Teixeira P, Gouveia IC (2017) Immobilization of bacteriophage in wound-dressing nanostructure. Nanomedicine 13:2475–2484. https://doi.org/10.1016/j.nano.2017.08.008
O’Neill J (2016) Tackling drug-resistant infections globally: final report and recommendations. Review on Antimicrobial Resistance. https://amreview.org/sites/default/files/160525_Final%20paper_with%20cover.pdf. Accessed 19 May 2016
Oh JS, Cho D, Park TH (2005) Two-stage continuous operation of recombinant Escherichia coli using the bacteriophage lambda Q-vector. Bioprocess Biosyst Eng 28:1–7. https://doi.org/10.1007/s00449-005-0418-0
Palluk S, Arlow DH, de Rond T, Barthel S, Kang JS, Bector R, Baghdassarian HM, Truong AN, Kim PW, Singh AK, Hillson NJ, Keasling JD (2018) De novo DNA synthesis using polymerase-nucleotide conjugates. Nat Biotechnol 36:645–650
Pautot S, Frisken BJ, Weitz DA (2003) Engineering asymmetric vesicles. Proc Natl Acad Sci 100:10718–10721. https://doi.org/10.1073/pnas.1931005100
Pearson HA, Sahukhal GS, Elasri MO, Urban MW (2013) Phage-bacterium war on polymeric surfaces: can surface-anchored bacteriophages eliminate microbial infections? Biomacromolecules 14:1257–1261
Peltomaa R, López-Perolio I, Benito-Peña E, Barderas R, Moreno-Bondi MC (2016) Application of bacteriophages in sensor development. Anal Bioanal Chem 408:1805–1828. https://doi.org/10.1007/s00216-015-9087-2
Philip AK, Philip B (2010) Colon targeted drug delivery systems: a review on primary and novel approaches. Oman Med J 25:79–87. https://doi.org/10.5001/omj.2010.24
Pichai MV, Ferguson LR (2012) Potential prospects of nanomedicine for targeted therapeutics in inflammatory bowel diseases. World J Gastroenterol 18:2895–2901
Pirnay JP, De Vos D, Verbeken G, Merabishvili M, Chanishvili N, Vaneechoutte M, Zizi M, Laire G, Lavigne R, Huys I, Van den Mooter G, Buckling A, Debarbieux L, Pouillot F, Azeredo J, Kutter E, Dublanchet A, Górski A, Adamia R (2011) The phage therapy paradigm: prêt-à-porter or Sur-mesure? Pharm Res 28:934–937
Pirnay JP, Verbeken G, Ceyssens PJ, Huys I, De Vos D, Ameloot C, Fauconnier A (2018) The magistral phage. Viruses 10(2):64. https://doi.org/10.3390/v10020064
Puapermpoonsiri U, Spencer J, Van Der Walle CF (2009) A freeze-dried formulation of bacteriophage encapsulated in biodegradable microspheres. Eur J Pharm Biopharm 72:26–33. https://doi.org/10.1016/j.ejpb.2008.12.001
Puapermpoonsiri U, Ford SJ, van der Walle CF (2010) Stabilization of bacteriophage during freeze drying. Int J Pharm 389:168–175. https://doi.org/10.1016/j.ijpharm.2010.01.034
Queval CJ, Brosch R, Simeone R (2017) The macrophage: a disputed fortress in the battle against Mycobacterium tuberculosis. Front Microbiol 8:2284. https://doi.org/10.3389/fmicb.2017.02284
Reshetnikov V, Kazianin A, Efimova N, Kameneva M (2002) Pharmatsevticheskaia kompozitsia, soderjashchaia bakteriofagi, i sposob ie poluchenia (pharmaceutical composition, containing bacteriophages and method of preparation). Russian Patent 2,241,446 C2
Reyes A, Haynes M, Hanson N, Angly FE, Heath AC, Rohwer F, Gordon JI (2010) Viruses in the fecal microbiota of monozygotic twins and their mothers. Nature 466:334–338
Richter Å, Matuła K, Lesniewski A, Kwasnicka K, Łos J, Łos M, Paczesny J, Hołyst R (2016) Ordering of bacteriophages in the electric field: application for bacteria detection. Sensors Actuators B Chem 224:233–240. https://doi.org/10.1002/9780470015902.a0024053
Rios AC, Moutinho CG, Pinto FC, Del Fiol FS, Jozala A, Chaud MV, Vila MM, Teixeira JA, Balcão VM (2016) Alternatives to overcoming bacterial resistances: state-of-the-art. Microbiol Res 191:51–80. https://doi.org/10.1016/j.micres.2016.04.008
Rustad M, Eastlund A, Jardine P, Noireaux V (2018) Cell-free TXTL synthesis of infectious bacteriophage T4 in a single test tube reaction. Synth Biol 3(1):ysy002. https://doi.org/10.1093/synbio/ysy002
Ryan EM, Alkawareek MY, Donnelly RF, Gilmore BF (2012) Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro. FEMS Immunol Med Microbiol 65:395–398. https://doi.org/10.1111/j.1574-695X.2012.00977.x
Saez AC, Zhang J, Rostagno MH, Ebner PD (2011) Direct feeding of microencapsulated bacteriophages to reduce Salmonella colonization in pigs. Foodborne Pathog Dis 8:1269–1274
Sağlam D, Venema P, de Vries R, Sagis LMC, van der Linden E (2011) Preparation of high protein micro-particles using two-step emulsification. Food Hydrocoll 25:1139–1148. https://doi.org/10.1016/j.foodhyd.2010.10.011
Salalha W, Kuhn J, Dror Y, Zussman E (2006) Encapsulation of bacteria and viruses in electrospun nanofibres. Nanotechnology 17:4657–46581. https://doi.org/10.1088/0957-4484/17/18/025
Salehi AS, Smith MT, Bennett AM, Williams JB, Pitt WG, Bundy BC (2016) Cell-free protein synthesis of a cytotoxic cancer therapeutic: onconase production and a just-add-water cell-free system. Biotechnol J 11:274–281. https://doi.org/10.1002/biot.201500237
Samtlebe M, Ergin F, Wagner N, Neve H, Küçükçetin A, Franz CMAP, Heller KJ, Hinrichs J, Atamer Z (2016) Carrier systems for bacteriophages to supplement food systems: encapsulation and controlled release to modulate the human gut microbiota. LWT - Food Sci Technol 68:334–340. https://doi.org/10.1016/j.lwt.2015.12.039
Santos SB, Kropinski AM, Ceyssens PJ, Ackermann HW, Villegas A, Lavigne R, Krylov VN, Carvalho CM, Ferreira EC, Azeredo J (2011) Genomic and proteomic characterization of the broad-host-range Salmonella phage PVP-SE1: creation of a new phage genus. J Virol 85:11265–11273. https://doi.org/10.1128/JVI.01769-1
Sarhan AW, Azzazy HME (2017) Apitherapeutics and phage-loaded nanofibers as wound dressings with enhanced wound healing and antibacterial activity. Nanomedicine 12:2055–2067
Sauvageau D, Cooper DG (2010) Two-stage, self-cycling process for the production of bacteriophages. Microb Cell Factor 9:81. https://doi.org/10.1186/1475-2859-9-81
Sauvageau D, Storms Z, Cooper DG (2010) Synchronized populations of Escherichia coli using simplified self-cycling fermentation. J Biotechnol 149:67–73. https://doi.org/10.1016/j.jbiotec.2010.06.018
Schmidt C, Lautenschlaeger C, Collnot EM, Schumann M, Bojarski C, Schulzke JD, Lehr CM, Stallmach A (2013) Nano- and microscaled particles for drug targeting to inflamed intestinal mucosa: a first in vivo study in human patients. J Control Release 165:139–145
Schnupf P, Portnoy DA (2007) Listeriolysin O: a phagosome-specific lysin. Microbes Infect 9:1176–1187
Scott H, Mattey M (2008) Immobilisation and stabilisation of virus. US 2009/0214617 A1
Shaw KJ (2017) Therapeutic bacteriophage compositions. US 2017/0065649 A1
Silva PS, Dragosavac MM, Vladisavljevic GT, Bandulasena HCH, Holdich RG, Stillwell M, Williams B (2015) Azimuthally oscillating membrane emulsification for controlled droplet production. AICHE J 61:3607–3615. https://doi.org/10.1002/aic
Singh A, Glass N, Tolba M, Brovko L, Griffiths M, Evoy S (2009) Immobilization of bacteriophages on gold surfaces for the specific capture of pathogens. Biosens Bioelectron 24:3645–3651. https://doi.org/10.1016/j.bios.2009.05.028
Singla S, Harjai K, Katare OP, Chhibber S (2015) Bacteriophage-loaded nanostructured lipid carrier: improved pharmacokinetics mediates effective resolution of Klebsiella pneumoniae-induced lobar pneumonia. J Infect Dis 212:325–334. https://doi.org/10.1093/infdis/jiv029
Singla S, Harjai K, Katare OP, Chhibber S (2016a) Encapsulation of bacteriophage in liposome accentuates its entry in to macrophage and shields it from neutralizing antibodies. PLoS One 11:e0153777. https://doi.org/10.1371/journal.Pone.0153777
Singla S, Harjai K, Raza K, Wadhwa S, Katare OP, Chhibber S (2016b) Phospholipid vesicles encapsulated bacteriophage: a novel approach to enhance phage biodistribution. J Virol Methods 236:68–76. https://doi.org/10.1016/j.jviromet.2016.07.002
Smrekar F, Ciringer M, Peterka M, Podgornik A, Strancar A (2008) Purification and concentration of bacteriophage T4 using monolithic chromatographic supports. J Chromatogr B 861:177–180. https://doi.org/10.1016/j.jchromb.2007.05.048
Smrekar F, Ciringer M, Jančar J, Raspor P, Štrancar A, Podgornik A (2011a) Optimization of lytic phage manufacturing in bioreactor using monolithic supports. J Sep Sci 34:2152–2158
Smrekar F, Ciringer M, Strancar A, Podgornik A (2011b) Characterisation of methacrylate monoliths for bacteriophage purification. J Chromatogr A 1218:2438–2444. https://doi.org/10.1016/j.chroma.2010.12.083
Stanford K, Niu YD, Johnson R (2010) Oral delivery systems for encapsulated bacteriophages targeted at Escherichia coli O157: H7 in feedlot cattle. J Food Prot 73:1304–1312
Sulakvelidze A, Kutter E (2005) Bacteriophage therapy in humans. In: Kutter E, Sulakvelidze A (eds) Bacteriophages: biology and applications. CRC, Boca Raton, pp 381–436
Sulakvelidze A, Morris G, Alavidze Z, Pasternack G, Brown T (2001) Method and device for sanitation using bacteriophages. US Patent 6,699,701 B1
Sulakvelidze A, Sozhamamnnan S, Pasternack G (2004) Salmonella bacteriophage and uses thereof. US Patent 7,674,467 B2
Summers WC (1999) Félix d’Herelle and the origins of molecular biology. Yale University Press, New Haven
Sun W, Brovko L, Griffiths M (2001) Use of bioluminescent Salmonella for assessing the efficiency of constructed phage-based biosorbent. J Ind Microbiol Biotechnol 27:126–128. https://doi.org/10.1038/sj/jim/7000198
Surh J, Mun S, McClements DJ (2007) Preparation and characterization of water/oil and water/oil/water emulsions containing biopolymer-gelled water droplets. J Agric Food Chem 55:175–184
Takeuchi H, Matsui Y, Sugihara H, Yamamoto H, Kawashima Y (2005) Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs. Int J Pharm 303:160–170
Tang Z, Huang X, Baxi S, Chambers JR, Sabour PM, Wang Q (2013) Whey protein improves survival and release characteristics of bacteriophage Felix O1 encapsulated in alginate microspheres. Food Res Int 52:460–466. https://doi.org/10.1016/j.foodres.2012.12.037
Tang Z, Huang X, Sabour PM, Chambers JR, Wang Q (2015) Preparation and characterization of dry powder bacteriophage K for intestinal delivery through oral administration. LWT - Food Sci Technol 60:263–270. https://doi.org/10.1016/j.lwt.2014.08.012
Tawil N, Sacher E, Mandeville R, Meunier M (2013) Strategies for the immobilization of bacteriophages on gold surfaces monitored by surface plasmon resonance and surface morphology. J Phys Chem C 117:6686–6691. https://doi.org/10.1021/jp400565m
Tawil N, Sacher E, Rioux D, Mandeville R, Meunier M (2015) Surface chemistry of bacteriophage and laser ablated nanoparticle complexes for pathogen detection. J Phys Chem C 119:14375–14382. https://doi.org/10.1021/acs.jpcc.5b02169
Telko MJ, Hickey AJ (2005) Dry powder inhaler formulation. Respir Care 50:1209–1227. https://doi.org/10.2165/00128413-200615470-00016
Thirawong N, Thongborisute J, Takeuchi H, Sriamornsak P (2008) Improved intestinal absorption of calcitonin by mucoadhesive delivery of novel pectin-liposome nanocomplexes. J Control Release 125:236–245. https://doi.org/10.1016/j.Jconrel.2007.10.023
Toh MR, Chiu GNC (2013) Liposomes as sterile preparations and limitations of sterilisation techniques in liposomal manufacturing. Asian J Pharm Sci 8:88–95
Tolba M, Minikh O, Brovko LY, Evoy S, Griffiths MW (2010) Oriented immobilization of bacteriophages for biosensor applications. Appl Environ Microbiol 76:528–535. https://doi.org/10.1128/AEM.02294-09
Torchilin VP (2005) Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4:145–160. https://doi.org/10.1038/nrd1632
United States Pharmacopeia and National Formulary (2007) Globule size distribution in lipid injectable emulsions. United States Pharmacopeia convention USP 32-NF 27, Rockville, MD, pp 3968–3970
Urban MW, Elasri MO (2014) Covalent attachment of bacteriophages (phages) to polymeric surfaces. US 2016/0010077 A1
Van Citters GW, Lin HC (2006) Ileal brake: neuropeptidergic control of intestinal transit. Curr Gastroenterol Rep 8:367–373. https://doi.org/10.1007/s11894-006-0021-9
Vandenheuvel D, Singh A, Vandersteegen K, Klumpp J, Lavigne R, Van Den Mooter G (2013) Feasibility of spray drying bacteriophages into respirable powders to combat pulmonary bacterial infections. Eur J Pharm Biopharm 84:578–582. https://doi.org/10.1016/j.ejpb.2012.12.022
Vandenheuvel D, Meeus J, Lavigne R, Van Den Mooter G (2014) Instability of bacteriophages in spray-dried trehalose powders is caused by crystallization of the matrix. Int J Pharm 472:202–205. https://doi.org/10.1016/j.ijpharm.2014.06026
Verbeken G, Pirnay JP, Lavigne R, Jennes S, De Vos D, Casteels M, Huys I (2014) Call for a dedicated European legal framework for bacteriophage therapy. Arch Immunol Ther Exp 62:117–129
Vinner GK, Malik DJ (2018) High precision microfluidic microencapsulation of bacteriophages for enteric delivery. Res Microbiol 169(9):522–530. https://doi.org/10.1016/j.resmic.2018.05.011
Vinner GK, Vladisavljevic GT, Clokie MRJ, Malik DJ (2017) Microencapsulation of Clostridium difficile specific bacteriophages using microfluidic glass capillary devices for colon delivery using pH triggered release. PLoS One 12:1–27. https://doi.org/10.1371/journal.pone.0186239
Vladisavljevic GT, Williams RA (2005) Recent developments in manufacturing emulsions and particulate products using membranes. Adv Colloid Interf Sci 113:1–20. https://doi.org/10.1016/j.cis.2004.10.002
Vladisavljević GT, Williams RA (2006) Manufacture of large uniform droplets using rotating membrane emulsification. J Colloid Interface Sci 299:396–402. https://doi.org/10.1016/j.jcis.2006.01.061
Vladisavljević GT, Kobayashi I, Nakajima M (2012) Production of uniform droplets using membrane, microchannel and microfluidic emulsification devices. Microfluid Nanofluid 13:151–178. https://doi.org/10.1007/s10404-012-0948-0
Voroshilova N, Kazakova T, Gorbatkova G, Bogovazova G, Afanasieva E, Bondarenko V (1992) Sposob poluchenia piobakteriofaga (method of production of Pyobacteriophage). Russian Patent 2,036,232 C1
Walbeck AK (2008) Methods for drying bacteriophage and bacteriophage-containing compositions, the resulting dry compositions, and methods of use. US Patent 8,501,453 B2
Wall SK, Zhang J, Rostagno MH, Ebner PD (2010) Phage therapy to reduce preprocessing Salmonella infections in market-weight swine. Appl Environ Microbiol 76:48–53. https://doi.org/10.1128/AEM.00785-09
Wang W (2000) Lyophilization and development of solid protein pharmaceuticals. Int J Pharm 203:1–60. https://doi.org/10.1016/S0378-5173(00)00423-3
Wang CH, Sauvageau D, Elias A (2016) Immobilization of active bacteriophages on polyhydroxyalkanoate surfaces. ACS Appl Mater Interfaces 8:1128–1138. https://doi.org/10.1021/acsami.5b08664
Weber-Dabrowska B, Mulczyk M, Gorski A, Boratynski J, Lusiak-Szelachowska M, Syper D (2002) Methods of polyvalent bacteriophage preparation for the treatment of bacterial infections. European Patent 1,406,642 B1
Weers J (2015) Inhaled antimicrobial therapy - barriers to effective treatment. Adv Drug Deliv Rev 85:24–43. https://doi.org/10.1016/j.addr.2014.08.013
Weinberger A, Tsai FC, Koenderink GH, Schmidt TF, Itri R, Meier W, Schmatko T, Schröder A, Marques C (2013) Gel assisted formation of giant unilamellar vesicles. Biophys J 105:154–164. https://doi.org/10.1016/j.bpj.2013.05.024
Xiao B, Laroui H, Ayyadurai S, Viennois E, Charania MA, Zhang Y, Merlin D (2013) Mannosylated bioreducible nanoparticle-mediated macrophage-specific TNF-alpha RNA interference for IBD therapy. Biomaterials 34:7471–7482
Yang LC, Tam PY, Murray BJ, Mcintire TM, Overstreet CM, Weiss GA, Oenner RM (2006) Virus electrodes for universal biodetection. Anal Chem 78:3265–3270
Yosef I, Goren MG, Globus R, Molshanski-Mor S, Qimron U (2017) Extending the host range of bacteriophage particles for DNA transduction. Mol Cell 66:721–728
Zhang H (2017) Thin-film hydration followed by extrusion method for liposome preparation. In: D’Souza GGM (ed) Liposomes: methods and protocols, Methods in molecular biology, vol 1522. Springer, New York, pp 17–22
Zhong W, Xing MM, Maibach HI (2010) Nanofibrous materials for wound care. Cutan Ocul Toxicol 29:143–152. https://doi.org/10.3109/15569527.2010.489307
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Merabishvili, M., Pirnay, JP., Vogele, K., Malik, D.J. (2019). Production of Phage Therapeutics and Formulations: Innovative Approaches. In: Górski, A., Międzybrodzki, R., Borysowski, J. (eds) Phage Therapy: A Practical Approach. Springer, Cham. https://doi.org/10.1007/978-3-030-26736-0_1
Download citation
DOI: https://doi.org/10.1007/978-3-030-26736-0_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-26735-3
Online ISBN: 978-3-030-26736-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)